Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel room-temperature synthesis method for 1,3-benzothiazepine intermediates. Reduces cost and lead time for pharmaceutical manufacturing significantly.
Patent CN113881720B reveals enzymatic synthesis for high-purity intermediates. Achieve cost reduction and supply chain reliability with scalable biocatalysis.
Patent CN102643246B details a novel ZnCl2-catalyzed synthesis of chiral oxazolines from TCNQ, offering streamlined production and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN103276025A details a high-purity enzymatic route for L-heterocyclic amino acids, offering significant cost and supply chain advantages for API manufacturing.
Patent CN106480157A details ionic liquid enzyme method for high-purity rare ginsenosides, ensuring scalable supply chain solutions.
Novel B(C6F5)3 catalyzed dehydration route offers >99% purity and reduced waste for reliable pharmaceutical intermediate supply chains.
Patent CN104557867A reveals a high-purity Esomeprazole Sodium method. This report analyzes cost reduction and supply chain reliability for global buyers.
Novel silver-catalyzed method for alpha,alpha-gem-difluoro carbonyls. High yield, mild conditions, scalable for pharma intermediates.
Patent CN113429439A details a high-yield synthesis of GS-101, a key tenofovir prodrug intermediate, offering significant cost reduction in API manufacturing through optimized catalytic conditions.
Novel three-step route for Carbamazepine intermediate ensures high purity and reduced waste for scalable API manufacturing supply chains.
Patent CN120329223A reveals a green one-pot synthesis for Tembotrione. This report analyzes cost reduction in herbicide manufacturing and supply chain reliability for global buyers.
Novel BsLDH mutant enables efficient chiral amino acid synthesis. Reduces costs and improves supply chain reliability for pharmaceutical intermediates.
Patent CN114773284B details a visible light-mediated synthesis of dihydroisoxazoles using terminal olefins. Offers mild conditions and cost-effective raw materials for pharmaceutical intermediates.
Patent CN113912645B details a novel low-temp reduction of triphenylphosphine dichloride using sodium hydride derivatives, offering high purity and cost efficiency for pharma intermediates.
Advanced low-temperature catalytic process for 4,6-dichloropyrimidine. High yield, recyclable catalysts, cost-effective pharmaceutical intermediate manufacturing.
Patent CN105624128B reveals a robust immobilized enzyme process for synthesizing key HCV drug intermediates, offering superior stability and cost efficiency.
Patent CN108358880A reveals ionic liquid catalysis for high-purity 4H-benzo[b]pyran compounds. Achieve cost reduction in pharmaceutical intermediates manufacturing with solvent-free technology.
Patent CN111960997B reveals a mild silver-catalyzed route for hydroxyalkyl quinolines, offering cost reduction and high purity for pharmaceutical intermediate manufacturing.
Patent CN104480181B reveals enzymatic D-7-ACA synthesis. High purity and yield offer supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN112979645B reveals a novel Lewis acid-catalyzed route for indolizine derivatives, offering significant cost reduction and green chemistry benefits for API manufacturing.